Moneycontrol
Get App
SENSEX NIFTY
you are here:

Sanofi India Ltd.

BSE: 500674 | NSE: SANOFI |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE058A01010 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 17, 16:00
6718.95 -1.65 (-0.02%)
Volume
AVERAGE VOLUME
5-Day
235
10-Day
244
30-Day
205
933
  • Prev. Close

    6720.60

  • Open Price

    6737.10

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 17, 15:57
6723.15 7.70 (0.11%)
Volume
AVERAGE VOLUME
5-Day
5,980
10-Day
6,432
30-Day
6,082
3,284
  • Prev. Close

    6715.45

  • Open Price

    6748.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    6723.15 (16)

ANNOUNCEMENTS ON Sanofi India

  • Jan 15, 2020 15:45 Source: BSE

    Sanofi India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.

  • Jan 13, 2020 15:02 Source: BSE

    Sanofi India - Statement Of Investor Complaints For The Quarter Ended December 2019

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0220
    Name of the Signatory :- Girish Tekchandani
    Designation :- Company Secretary and Compliance Officer

  • Jan 09, 2020 12:56 Source: NSE

    Sanofi India Limited

    Sanofi India Limited has informed the Exchange regarding ''Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations. 2018 for the fourth quarter ended 31st December 2019''.

  • Jan 09, 2020 11:49 Source: BSE

    Sanofi India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.

  • Jan 09, 2020 11:43 Source: BSE

    Sanofi India - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    The details of securities dematerialized during the quarter ended 31st December 2019, has been submitted by Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed as per the requirements prescribed under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. A certificate confirming the said compliance received from our RTA is enclosed for your reference.

  • Jan 07, 2020 13:47 Source: BSE

    Sanofi India - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1Name of CompaySanofi India Ltd
    2CINL24239MH1956PLC009794
    3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00
    4Highest Credit Rating during the previous FY NA
    4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
    5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE


    We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No



    Name of the Company Secretary: Girish Tekchandani
    Designation: Company Secretary
    EmailId: Girish.Tekchandani@sanofi.com
    Name of the Chief Financial Officer: Charles Billard
    Designation: Whole Time Director and Chief Financial Officer
    EmailId: Charles.Billard@sanofi.com

    Date: 07/01/2020

    Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

  • Jan 06, 2020 15:26 Source: BSE

    Sanofi India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.

  • Jan 02, 2020 13:50 Source: BSE

    Sanofi India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.

  • Dec 19, 2019 12:26 Source: BSE

    Sanofi India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.

  • Dec 10, 2019 16:21 Source: BSE

    Sanofi India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Nov 12, 2019
Remark : Quarterly Results